Spero Therapeutics(SPRO) - 2024 Q4 - Earnings Call Transcript

Spero Therapeutics (SPRO) Q4 2024 Earnings Call March 27, 2025 10:33 PM ET Company Participants Shai Biran - Investor RelationsEsther Rajavelu - Interim CEO & CFOTimothy Keutzer - COO Conference Call Participants Gavin Clark-Gartner - AnalystAthena Chin - Biotechnology Equity Research Analyst Operator Good afternoon, and welcome to the Spirit Therapeutics Fourth Quarter and Full Year twenty twenty four Earnings Conference Call. At this time, all participants are in listen only mode. Following the company's ...